Education
PhD Epidemiology, University of Washington, 2010
MHS International Health, Johns Hopkins University, 2002
BS Biology, Calvin College, 2000
Contact
Bio
Jonathan Sugimoto is an Epidemiologist and Investigator with the Seattle Epidemiologic Research and Information Center (ERIC) at the United States Department of Veteran Affairs (VA) Puget Sound Health Care Medical Center, Seattle WA. The Seattle ERIC one of a network of Epidemiology Centers supported by the Cooperative Studies Program of the VA’s Office of Research and Development.
Research Areas
Research Interests
Dr. Jonathan Sugimoto is a quantitative infectious disease epidemiologist whose research focuses on the estimation and modeling of the burden and prevention of communicable pathogens in humans. His research experience extends from designing, implementing, analyzing, and reporting observational field studies and randomized vaccine trials, to developing and applying statistical methods and models for reducing bias in observational/ecological studies of vaccine efficacy/effectiveness. He has used a wide variety of statistical methods and approaches to infer and model vaccine-preventable disease burden and vaccine effects for populations that range from the very local to the global. Jonathan also has experience applying geostatistical methods to geolocated infectious disease and nutritional epidemiologic data. Dr. Sugimoto has conducted global health research across sub-Saharan Africa and South Asia. Recently, Dr. Sugimoto’s work has focused on the design and analysis of studies and trial of the effectiveness of vaccines against neglected enteric diseases in low-resource tropical settings, such as typhoid, cholera, and rotavirus.
Dr. Sugimoto recently joined the Seattle Epidemiologic Research and Information Center (VA Puget Sound Health Care System), where he is an investigator with several SARS-CoV-2/COVID-19 related projects, including serving as the Program Director for a national prospective cohort study (CSP #2028) of the natural history, immune response, transmission, and clinical outcomes of symptomatic SARS-CoV-2 infection among Veteran-users of the VA health care system.
Recent Publications (PubMed)
(2024 Oct)
J Infect 89(4): 106260
Aziz AB, Sugimoto JD, Hong SL, You YA, Bravo L, Roa C Jr, Borja-Tabora C, Montellano MEB, Carlos J, de Los Reyes MRA, Alberto ER, Salvani-Bautista M, Kim HY, Njau I, Clemens R, Marks F, Tadesse BT
(2024 Apr)
Lancet Glob Health 12(4): e599-e610
Marks F, Im J, Park SE, Pak GD, Jeon HJ, Wandji Nana LR, Phoba MF, Mbuyi-Kalonji L, Mogeni OD, Yeshitela B, Panzner U, Cruz Espinoza LM, Beyene T, Owusu-Ansah M, Twumasi-Ankrah S, Yeshambaw M, Alemu A, Adewusi OJ, Adekanmbi O, Higginson E, Adepoju A, Agbi S, Cakpo EG, Ogunleye VO, Tunda GN, Ikhimiukor OO, Mbuyamba J, Toy T, Agyapong FO, Osei I, Amuasi J, Razafindrabe TJL, Raminosoa TM, Nyirenda G, Randriamampionona N, Seo HW, Seo H, Siribie M, Carey ME, Owusu M, Meyer CG, Rakotozandrindrainy N, Sarpong N, Razafindrakalia M, Razafimanantsoa R, Ouedraogo M, Kim YJ, Lee J, Zellweger RM, Kang SSY, Park JY, Crump JA, Hardy L, Jacobs J, Garrett DO, Andrews JR, Poudyal N, Kim DR, Clemens JD, Baker SG, Kim JH, Dougan G, Sugimoto JD, Van Puyvelde S, Kehinde A, Popoola OA, Mogasale V, Breiman RF, MacWright WR, Aseffa A, Tadesse BT, Haselbeck A, Adu-Sarkodie Y, Teferi M, Bassiahi AS, Okeke IN, Lunguya-Metila O, Owusu-Dabo E, Rakotozandrindrainy R
(2023 Jul)
Open Forum Infect Dis 10(7): ofad330
Ross JM, Sugimoto JD, Timmons A, Adams J, Deardoff K, Korpak A, Liu C, Moore K, Wilson D, Bedimo R, Chang KM, Cho K, Crothers K, Garshick E, Gaziano JM, Holodniy M, Hunt CM, Isaacs SN, Le E, Jones BE, Shah JA, Smith NL, Lee JS, EPIC Investigators
(2023 Apr 3)
Clin Infect Dis 76(7): 1180-1187
Tadesse BT, Bravo L, Marks F, Aziz AB, You YA, Sugimoto J, Li P, Garcia J, Rockhold F, Clemens R, Household Contact Study Group
(2022 Jan)
J R Stat Soc Ser C Appl Stat 71(1): 70-90
Potter GE, Carnegie NB, Sugimoto JD, Diallo A, Victor JC, Neuzil KM, Halloran ME
Show complete publication list